Summary
To explore the clinical value of contrast-enhanced ultrasound (CEUS) in differentiating benign and malignant focal liver lesions (FLLs) with SonoVue, CEUS was used to examine 113 patients with focal liver lesions (FLLs) in our hospital during July 2005 to December 2006. All the patients underwent contrast-enhanced CT (CECT) or contrast-enhanced MRI (CEMRI). Except for patients with focal fatty sparings (n=18) and with hemangiomas (n=8), all the patients were confirmed by operation or ultrasonic-guided liver puncture biopsy. A sulfur hexafluoride gas-based contrast agent was used with a MI of 0.15 to 0.17. Forty-eight cases of malignant FLLs, including 30 hepatocellular carcinomas (HCCs), 2 cholangiocarcinomas and 16 metastatic tumors, were detected. Seventy-eight cases of benign FLLs, including 33 hemangiomas, 9 focal nodular hyperplasias (FNHs), 19 focal fatty sparings, 5 abscesses, 7 regenerative nodules and 2 inflammatory pseudo-tumor, were involved. The contrast pattern of benign and malignant FLLs was quite different. CEUS has higher specificity and sensitivity than conventional ultrasound in differentiating benign and malignant FLLs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alexandea V H, Christoph V, Reinhard W et al. Real-time imaging with the sonographic contrast agent SonoVue. Radiology, 2004,23:1557–1568
Schneider M, Arditi M, Barrau M B et al. BR1: a new ultrasonographic contrast agent based on sulphur hexafluoride-filled microbubbles. Invest Radiol, 1995,30:451–457
Schneider M. SonoVue, a new ultrasound contrast agent. Eur Radiol, 1999,9(suppl 3):S347–S348
Hohmann J, Skok J, Puls R et al. Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue. Rofo, 2003,75:835–843
Yu X L, Dong B W, Liang P. Diagnosis of focal hepatic lesions with contrast-enhanced gray-scale ultrasonography with technique CPS and CCI. Chin J Medical Imaging Technol (Chinese), 2004,20(7):1080–1083
Leen E Angerson W J Yarmenitis S et al. Multi-centre clinical stydy evaluating efficacy of sonovue: a new ultrasound contrast agent in Doppler investigation of focal hepatic lesiong. Eur J Radiology, 2002,41(3):200–206
Solbiati L, Martegani A, Leen E et al. Contrast-enhanced ultrasound of liver diseases. Springer: Milan, 2003.61–65
Chen M H. Sonography for diseases of digestive tract. Beijing: Beijing Publishing House, 2003.74–118
Chen M H, Yan K, DDI Y. New gray scale contrast ultrasound technique in liver neoplasms diagnosis and radiofrequency ablation application. Chin J Medical Imaging Technol (Chinese), 2004,20(3):326–330
Chen M H, Yan K. The role of new contrast agent and contrast-enhanced gray-scale ultrasound in the diagnosis of liver neoplasms. Chin J Ultrason, 2004,13(1):38–42
Author information
Authors and Affiliations
Additional information
This project was supported by a key program from the National Natural Sciences Foundation of China (No. 90209009).
Rights and permissions
About this article
Cite this article
Xu, J., Wu, Y., Dong, F. et al. Clinical value of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 27, 703–705 (2007). https://doi.org/10.1007/s11596-007-0622-z
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11596-007-0622-z